KRT17 Antikörper
Kurzübersicht für KRT17 Antikörper (ABIN2462465)
Target
Alle KRT17 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Antibody is purified by peptide affinity chromatography method.
-
Immunogen
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human KRT17.
-
-
-
-
Applikationshinweise
- KRT17 antibody can be used for detection of KRT17 by ELISA at 1:312500. KRT17 antibody can be used for detection of KRT17 by western blot at 0.25 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
-
Konzentration
- 1 mg/mL
-
Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
-
Handhabung
- As with any antibody avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store KRT17 antibody at -20 °C.
-
-
- KRT17 (Keratin 17 (KRT17))
-
Andere Bezeichnung
- KRT17
-
Hintergrund
- KRT17 is type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in its gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
-
Molekulargewicht
- 48 kDa
-
Gen-ID
- 3872
-
NCBI Accession
- NP_000413
-
UniProt
- Q04695
Target
-